Evercore ISI analyst Elizabeth Anderson CFA maintained a Hold rating on Henry Schein (NASDAQ:HSIC) on Wednesday, setting a price target of $84, which is approximately 6.45% above the present share price of $78.91.
Anderson CFA expects Henry Schein to post earnings per share (EPS) of $1.00 for the second quarter of 2021.
The current consensus among 6 TipRanks analysts is for a Moderate Buy rating of shares in Henry Schein, with an average price target of $85.5.
The analysts price targets range from a high of $99 to a low of $79.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $3.17 billion and a net profit of $185.58 million. The company's market cap is $11.23 billion.
According to TipRanks.com, Evercore ISI analyst Elizabeth Anderson CFA is currently ranked with 1 stars on a 0-5 stars ranking scale, with an average return of -2.6% and a 46.15% success rate.
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.